ILSI-Biomed Israel

Researchers from RAMBAM Hospital Fight Parkinson’s Disease with Imagination

A new research from RAMBAM hospital shows that Guided Affective Imagery (דמיון מודרך) can make the tremors of Parkinson's disease go away. The relationship between the mind and the body has never been fully determined. Worse, the field is wide open for charlatans, holistic healers, homeopaths, naturopaths and what-have-you. However, from time to time we get some ‘real’ peer-reviewed scientific papers that offer new insights on the mind-body link. Such a paper was recently published in the...

Cardiovascular Therapy in the 2020s

As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv This message is also available online   Cardiovascular Therapy in the 2020s An ILSI-BioMed Workshop Sponsored by As part of the BioMed Conference, a Cardiovascular Technology Workshop will be held on Monday, June 14, 12:00–18:30 at the Dan Panorama Hotel, Tel Aviv.The most acclaimed inte...

Human Beta Cells Grown in a Culture

From BioMed Israel Week 2010: A Novel Therapeutic Method Based on the Ability of Stem Cells to Assist in Treating Juvenile Diabetes Will Replace the Insulin Injection Ramot, Tel Aviv University's technology transfer company, will present for the first time a therapeutic approach based on stem cells capability to assist in the treatment of juvenile diabetes, in the Israel BioMed Week 2010, which will be held on the 14th-16th of June in Tel Aviv. The main novelty of the treatment is a br...

Networking with Five Italian Companies

Five Italian biomedical companies are coming to Israel, and are interested in meeting suitable Israeli business partners It’s not WHAT you know, it’s WHO you know! Relationships are the catalyst for success! Do the above two statements look familiar? They should. They are the axioms of the Networking Theory (name not trademarked, invented on the spot). While networking seems to be the new religion of the business folks, I daresay that it’s been around for quite a bit. Even apes have...

A Novel Artificial Pancreas System

An aritifical pancreas system that maintains near-normal glucose levels by injecting both insulin and glucagon was succesfully demonstrated on a small number of patients An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin an...

Enzymotec: a $20 M Deal with Daiichi Sankyo

Israeli biotech company Enzymotec Ltd., a developer of active pharmaceutical ingredients for nutritional supplements, has signed a major strategic agreement with Daiichi Sankyo Brazil, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. (TSE: 4568). Globes, 6 May Enzymotec and Daiichi Sankyo Brazil will launch Enzymotec's product for the reduction of cholesterol and triglycerides, which Daiichi Sankyo Brazil will market. Daiichi Sankyo Brazil focuses on cardiology a...

Antioxidants Cause Genetic Abnormalities?

A new research reveals that high doses of antioxidants cause stem cells to develop genetic abnormalities, paving the way for cancer When people look back on the beginning of the 21st century, they might think this was the time of the antioxidants. Antioxidants supplements are being sold everywhere, usually without a doctor prescription, as a way to halt aging, heart diseases and whatever else is promised on the label. But current research, published online in the medical journal Stem Cells, r...

Medtronic buys ATS: Cardiology Shopping Spree Is Not Over

Last week Medtronic announced its plan to acquire the American ATS Medical for $370 million in cash and debt - an offer that represents a 54 percent premium over ATS Medical’s closing price of $2.54 the day before. The move is supposed to strengthen Medtronic's position in the expanding cardiovascular market. It adds to a series of purchases made by the medical device giant in the last two years, paying a total of more than $2 Billion. In 2009, Medtronic has spent over $1 billion to ...

May 5th: Healthcare Reform Webinar

U.S. Health Care Reform Webinar - A Special Presentation for Israeli Pharma, Biotech and Medical Device Companies and Their Investors     Please register for this live webinar.   Meeting Description:    Drug and Biologics Manufacturers: Medicare and Medicaid drug coverage changes Annual fee for branded prescription drug manufacturers Biosimilars   Medical Device Manufacturers: Excise tax Essential Health Benefits Package   Heal...

The Power Solution: Thermoelectric Generators to Sustain Implanted Medical Devices

Efficient thermoelectric generators were recently published as a possibly efficient way to sustain implanted medical devices Let's face it: we're dealing with an aging population. There's no way around this fact, and the obvious implication is that in the future we're going to need better heart pacemakers and better systems for insulin injection. The future seems to be heading towards more sophisticated implantable machinery, be it pacemakers or sustainable drug-release devices inside the bod...